Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Christoph J. Schankin
Sort by Type
Date
Speaker
ePoster
P148
Fremanezumab for the prevention of menstrually-related migraine attacks – a prospective observational phase 4 study according to routine neurological care in Switzerland (FROMM)
Further involvements
ePoster
P148
Fremanezumab for the prevention of menstrually-related migraine attacks – a prospective observational phase 4 study according to routine neurological care in Switzerland (FROMM)
ePoster
P183
Impact of Fremanezumab cessation and reinitiation in migraine management: PEARL study 4th interim analysis
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy